Both the AstraZeneca and Pfizer-BioNTech COVID-19 vaccines maintained effectiveness against the Delta variant in a recent study, with researchers noting “no evidence of widespread complete escape from neutralization.”

Both the AstraZeneca and Pfizer-BioNTech COVID-19 vaccines maintained effectiveness against the Delta variant in a recent study, with researchers noting “no evidence of widespread complete escape from neutralization.”